Capone, S., Raggioli, A., Gentile, M., Battella, S., Lahm, A., Sommella, A., … Vitelli, A. (2021). Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19. Molecular Therapy : The Journal of the American Society of Gene Therapy, 29(8), 2412-2423. https://doi.org/10.1016/j.ymthe.2021.04.022 (Original work published 2021)
Covid-19
Malahe, R., Hartog, Y., Rietdijk, W., van Baarle, D., de Kuiper, R., Reijerkerk, D., … collaborators, R. (2023). The role of interleukin-21 in COVID-19 vaccine-induced B cell-mediated immune responses in patients with kidney disease and kidney transplant recipients. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 23(9), 1411-1424. https://doi.org/10.1016/j.ajt.2023.05.025 (Original work published 2023)
Awadalla, M., AlRawi, H., Henawi, R., Barnawi, F., Alkadi, H., Alyami, A., … Alosaimi, B. (2025). Humoral and cellular immune durability of different COVID-19 vaccine platforms following homologous/heterologous boosters: one-year post vaccination. Frontiers in Immunology, 16, 1526444. https://doi.org/10.3389/fimmu.2025.1526444 (Original work published 2025)
Ma, X., Zou, F., Yu, F., Li, R., Yuan, Y., Zhang, Y., … Zhang, H. (2020). Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses. Immunity, 53(6), 1315-1330.e9. https://doi.org/10.1016/j.immuni.2020.11.015 (Original work published 2020)
Zhao, B., Zhong, M., Yang, Q., Hong, K., Xia, J., Li, X., … Yan, H. (2021). Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study. Virologica Sinica, 36(5), 859-868. https://doi.org/10.1007/s12250-021-00348-0 (Original work published 2021)
Qu, L., Yi, Z., Shen, Y., Lin, L., Chen, F., Xu, Y., … Wei, W. (2022). Circular RNA vaccines against SARS-CoV-2 and emerging variants. Cell, 185(10), 1728-1744.e16. https://doi.org/10.1016/j.cell.2022.03.044 (Original work published 2022)
Volkmann, A., Koopman, G., Mooij, P., Verschoor, E., Verstrepen, B., Bogers, W., … Chaplin, P. (2022). A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques. Frontiers in Immunology, 13, 857440. https://doi.org/10.3389/fimmu.2022.857440 (Original work published 2022)
Mooij, P., García-Arriaza, J., Pérez, P., Lázaro-Frías, A., Verstrepen, B., Böszörményi, K., … Esteban, M. (2022). Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2. Frontiers in Immunology, 13, 845887. https://doi.org/10.3389/fimmu.2022.845887 (Original work published 2022)
An, Y., Li, S., Jin, X., Han, J.-B., Xu, K., Xu, S., … Gao, G. (2022). A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates. Emerging Microbes & Infections, 11(1), 1058-1071. https://doi.org/10.1080/22221751.2022.2056524 (Original work published 2022)
Van Coillie, J., Pongracz, T., Rahmöller, J., Chen, H.-J., Geyer, C., van Vught, L., … group, U. (2023). The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees. EBioMedicine, 87, 104408. https://doi.org/10.1016/j.ebiom.2022.104408 (Original work published 2023)